Engineered Bacterial Strain for One-Pot Vitamin C Synthesis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The current two-step fermentation process for producing vitamin C is inefficient, requiring separate fermentation vessels and enzymatic activities from different microbes, limiting production yield and increasing costs due to space and time constraints.
Innovation Solution
A single, engineered bacterial strain capable of expressing polyol dehydrogenase, sorbose dehydrogenase, and sorbosone dehydrogenase is used in a one-pot synthesis, allowing for the oxidation of D-sorbitol to 2-keto-gulonic acid within a single fermentation vessel, thereby simplifying the production process and reducing costs.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If a two-step fermentation process is used with separate fermenters, then enzymatic activities from different microbes can be utilized, but production yield is limited and space-time efficiency is reduced
Solution Approach 1:
The patent combines multiple enzymatic activities from different microbes (Gluconobacter oxydans and Ketogulonicigenium vulgare) into a single engineered bacterial strain. This allows the polyol dehydrogenase, sorbose dehydrogenase, and sorbosone dehydrogenase to coexist in one organism, enabling the entire vitamin C synthesis pathway to occur in a single fermenter rather than requiring separate fermentation steps.
Solution Approach 2:
The engineered bacterial strain is designed to perform multiple functions simultaneously: it expresses polyol dehydrogenase for sorbitol oxidation, sorbose dehydrogenase for intermediate conversion, and sorbosone dehydrogenase for final oxidation to 2-keto-L-gulonic acid. This multi-functional strain replaces the need for separate specialized strains in different fermenters.
2Loss of time
If a two-step fermentation process is used, then substrate conversion can proceed with specialized microbes, but time consumption increases and fermenter turnover is reduced
Solution Approach 1:
The engineered bacterial strain is pre-engineered to contain all necessary enzymatic pathways before fermentation begins. This eliminates the need for sequential inoculation and fermentation steps, allowing the complete vitamin C synthesis pathway to proceed simultaneously in a single fermenter, thereby reducing total fermentation time and increasing turnover.
3Ease of operation
If separate fermenters are used for different fermentation steps, then process control is simplified, but space requirements increase and operational complexity increases
Solution Approach 1:
The patent merges multiple fermentation processes into a single fermenter by using an engineered strain that performs all enzymatic conversions in one system. This reduces the total number of fermenters needed from two to one, halving the space requirements while maintaining process control through a single system.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach increases production yield and reduces costs by allowing simultaneous use of existing fermenters, minimizing space and time requirements, and eliminating the need for complex monitoring and frequent system resets, while maintaining high production capacity and output.
Implementation Method 1
oxidation of D-sorbitol to L-sorbose by a polyol dehydrogenase
Implementation Method 2
oxidation of the L-sorbose by a sorbose dehydrogenase and sorbosone dehydrogenase to 2-keto-gulonic acid
Implementation Method 3
a one-pot method for synthesizing L-ascorbic acid (vitamin C)... carried out in a single fermentation vessel
Data Source
AI summary
An engineered bacterial strain expressing dehydrogenases capable of oxidizing D- sorbitol to 2-keto-gulonic acid is provided by the present invention. Methods of using same in a one-pot synthesis of L-ascorbic acid (vitamin C) are also described.